vs
Side-by-side financial comparison of BJs RESTAURANTS INC (BJRI) and AMICUS THERAPEUTICS, INC. (FOLD). Click either name above to swap in a different company.
BJs RESTAURANTS INC is the larger business by last-quarter revenue ($355.4M vs $185.2M, roughly 1.9× AMICUS THERAPEUTICS, INC.). BJs RESTAURANTS INC runs the higher net margin — 3.6% vs 0.9%, a 2.6% gap on every dollar of revenue. On growth, AMICUS THERAPEUTICS, INC. posted the faster year-over-year revenue change (23.7% vs 3.2%). Over the past eight quarters, AMICUS THERAPEUTICS, INC.'s revenue compounded faster (29.5% CAGR vs 2.6%).
BJ's Restaurants Inc. operates a chain of casual dining restaurants across the United States. Its menu features signature deep-dish pizzas, craft beers, handcrafted cocktails, and a wide range of American comfort food. The brand primarily serves family groups, friend gatherings, and casual diners seeking affordable, high-quality meals in a relaxed, welcoming in-store environment.
Amicus Therapeutics, Inc. is a public American biopharmaceutical company based in Philadelphia, Pennsylvania. The company went public in 2007 under the Nasdaq trading symbol FOLD. This followed a 2006 planned offering and subsequent withdrawal, which would have established the trading symbol as AMTX Prior to their IPO, Amicus was funded by a variety of venture capital firms including Radius Ventures, Canaan Partners and New Enterprise Associates.
BJRI vs FOLD — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $355.4M | $185.2M |
| Net Profit | $12.6M | $1.7M |
| Gross Margin | 74.5% | 85.7% |
| Operating Margin | 3.1% | 8.6% |
| Net Margin | 3.6% | 0.9% |
| Revenue YoY | 3.2% | 23.7% |
| Net Profit YoY | -24.2% | -88.5% |
| EPS (diluted) | $0.58 | $0.00 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $355.4M | $185.2M | ||
| Q3 25 | $365.6M | $169.1M | ||
| Q2 25 | $348.0M | $154.7M | ||
| Q1 25 | — | $125.2M | ||
| Q4 24 | $325.7M | $149.7M | ||
| Q3 24 | $349.9M | $141.5M | ||
| Q2 24 | $337.3M | $126.7M | ||
| Q1 24 | — | $110.4M |
| Q4 25 | $12.6M | $1.7M | ||
| Q3 25 | $22.2M | $17.3M | ||
| Q2 25 | $13.5M | $-24.4M | ||
| Q1 25 | — | $-21.7M | ||
| Q4 24 | $-2.9M | $14.7M | ||
| Q3 24 | $17.2M | $-6.7M | ||
| Q2 24 | $7.7M | $-15.7M | ||
| Q1 24 | — | $-48.4M |
| Q4 25 | 74.5% | 85.7% | ||
| Q3 25 | 75.2% | 88.5% | ||
| Q2 25 | 75.0% | 90.2% | ||
| Q1 25 | — | 90.7% | ||
| Q4 24 | 73.4% | 90.1% | ||
| Q3 24 | 74.3% | 90.6% | ||
| Q2 24 | 74.8% | 91.1% | ||
| Q1 24 | — | 87.7% |
| Q4 25 | 3.1% | 8.6% | ||
| Q3 25 | 5.8% | 20.3% | ||
| Q2 25 | 4.3% | -6.1% | ||
| Q1 25 | — | -6.3% | ||
| Q4 24 | -0.8% | 10.7% | ||
| Q3 24 | 3.8% | 15.3% | ||
| Q2 24 | 2.4% | 11.8% | ||
| Q1 24 | — | -25.1% |
| Q4 25 | 3.6% | 0.9% | ||
| Q3 25 | 6.1% | 10.2% | ||
| Q2 25 | 3.9% | -15.8% | ||
| Q1 25 | — | -17.3% | ||
| Q4 24 | -0.9% | 9.8% | ||
| Q3 24 | 4.9% | -4.8% | ||
| Q2 24 | 2.3% | -12.4% | ||
| Q1 24 | — | -43.9% |
| Q4 25 | $0.58 | $0.00 | ||
| Q3 25 | $0.97 | $0.06 | ||
| Q2 25 | $0.58 | $-0.08 | ||
| Q1 25 | — | $-0.07 | ||
| Q4 24 | $-0.13 | $0.05 | ||
| Q3 24 | $0.72 | $-0.02 | ||
| Q2 24 | $0.32 | $-0.05 | ||
| Q1 24 | — | $-0.16 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $23.8M | $293.5M |
| Total DebtLower is stronger | — | $392.7M |
| Stockholders' EquityBook value | $366.2M | $274.2M |
| Total Assets | $1.0B | $949.9M |
| Debt / EquityLower = less leverage | — | 1.43× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $23.8M | $293.5M | ||
| Q3 25 | $26.0M | $263.8M | ||
| Q2 25 | $19.0M | $231.0M | ||
| Q1 25 | — | $250.6M | ||
| Q4 24 | $18.4M | $249.9M | ||
| Q3 24 | $16.2M | $249.8M | ||
| Q2 24 | $18.8M | $260.1M | ||
| Q1 24 | — | $239.6M |
| Q4 25 | — | $392.7M | ||
| Q3 25 | $60.5M | $392.0M | ||
| Q2 25 | $85.5M | $391.3M | ||
| Q1 25 | — | $390.7M | ||
| Q4 24 | $66.5M | $390.1M | ||
| Q3 24 | $63.5M | $389.5M | ||
| Q2 24 | $58.0M | $388.9M | ||
| Q1 24 | — | $388.4M |
| Q4 25 | $366.2M | $274.2M | ||
| Q3 25 | $386.6M | $230.4M | ||
| Q2 25 | $371.5M | $204.3M | ||
| Q1 25 | — | $193.6M | ||
| Q4 24 | $376.2M | $194.0M | ||
| Q3 24 | $386.5M | $178.8M | ||
| Q2 24 | $375.4M | $132.5M | ||
| Q1 24 | — | $130.7M |
| Q4 25 | $1.0B | $949.9M | ||
| Q3 25 | $1.0B | $868.8M | ||
| Q2 25 | $1.0B | $815.3M | ||
| Q1 25 | — | $789.8M | ||
| Q4 24 | $1.0B | $785.0M | ||
| Q3 24 | $1.0B | $786.6M | ||
| Q2 24 | $1.0B | $749.5M | ||
| Q1 24 | — | $721.8M |
| Q4 25 | — | 1.43× | ||
| Q3 25 | 0.16× | 1.70× | ||
| Q2 25 | 0.23× | 1.92× | ||
| Q1 25 | — | 2.02× | ||
| Q4 24 | 0.18× | 2.01× | ||
| Q3 24 | 0.16× | 2.18× | ||
| Q2 24 | 0.15× | 2.93× | ||
| Q1 24 | — | 2.97× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | — | $16.3M |
| Free Cash FlowOCF − Capex | — | $16.0M |
| FCF MarginFCF / Revenue | — | 8.6% |
| Capex IntensityCapex / Revenue | — | 0.2% |
| Cash ConversionOCF / Net Profit | — | 9.62× |
| TTM Free Cash FlowTrailing 4 quarters | — | $29.8M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $16.3M | ||
| Q3 25 | $62.3M | $35.7M | ||
| Q2 25 | $4.6M | $-26.5M | ||
| Q1 25 | — | $7.8M | ||
| Q4 24 | $27.3M | $-3.9M | ||
| Q3 24 | $20.2M | $-23.0M | ||
| Q2 24 | $22.3M | $22.7M | ||
| Q1 24 | — | $-29.7M |
| Q4 25 | — | $16.0M | ||
| Q3 25 | $41.9M | $35.3M | ||
| Q2 25 | $-12.1M | $-28.9M | ||
| Q1 25 | — | $7.5M | ||
| Q4 24 | $7.6M | $-4.2M | ||
| Q3 24 | $735.0K | $-23.3M | ||
| Q2 24 | $448.0K | $21.6M | ||
| Q1 24 | — | $-31.5M |
| Q4 25 | — | 8.6% | ||
| Q3 25 | 11.5% | 20.9% | ||
| Q2 25 | -3.5% | -18.7% | ||
| Q1 25 | — | 6.0% | ||
| Q4 24 | 2.3% | -2.8% | ||
| Q3 24 | 0.2% | -16.5% | ||
| Q2 24 | 0.1% | 17.0% | ||
| Q1 24 | — | -28.5% |
| Q4 25 | — | 0.2% | ||
| Q3 25 | 5.6% | 0.2% | ||
| Q2 25 | 4.8% | 1.6% | ||
| Q1 25 | — | 0.2% | ||
| Q4 24 | 6.0% | 0.2% | ||
| Q3 24 | 5.6% | 0.3% | ||
| Q2 24 | 6.5% | 0.9% | ||
| Q1 24 | — | 1.6% |
| Q4 25 | — | 9.62× | ||
| Q3 25 | 2.80× | 2.06× | ||
| Q2 25 | 0.34× | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | -0.27× | ||
| Q3 24 | 1.18× | — | ||
| Q2 24 | 2.89× | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
BJRI
Segment breakdown not available.
FOLD
| Other | $105.8M | 57% |
| Galafold | $64.8M | 35% |
| Pombiliti Opfolda | $14.6M | 8% |
